Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients.
In MS, Socio-Economic status (SES) may influence healthcare and access to disease-modifying treatments (DMTs). Optimising delays to switch patients to a second-line DMT may hamper disease progression most effectively and achieve long term disease control. The objective of this study is to identify t...
Main Authors: | Floriane Calocer, Olivier Dejardin, Karine Droulon, Guy Launoy, Gilles Defer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5794112?pdf=render |
Similar Items
-
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
by: Pierre Branger, et al.
Published: (2016-01-01) -
Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies
by: Kay, Kathleen Alexandra
Published: (2016) -
Natalizumab for relapsing-remitting multiple sclerosis
by: A. Horga, et al.
Published: (2011-01-01) -
Natalizumab for relapsing remitting multiple sclerosis
by: Pucci, Eugenio, et al.
Published: (2011) -
Disease-modifying therapies in relapsing–remitting multiple sclerosis
by: Fabricio González-Andrade, et al.
Published: (2010-07-01)